83 related articles for article (PubMed ID: 24150741)
1. Structure-activity relationship studies of the aromatic positions in cyclopentapeptide CXCR4 antagonists.
Mungalpara J; Zachariassen ZG; Thiele S; Rosenkilde MM; Våbenø J
Org Biomol Chem; 2013 Dec; 11(47):8202-8. PubMed ID: 24150741
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of scaffold-based tripeptidomimetic antagonists for CXC chemokine receptor 4 (CXCR4).
Zachariassen ZG; Thiele S; Berg EA; Rasmussen P; Fossen T; Rosenkilde MM; Våbenø J; Haug BE
Bioorg Med Chem; 2014 Sep; 22(17):4759-69. PubMed ID: 25082513
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship study of a CXC chemokine receptor type 4 antagonist, FC131, using a series of alkene dipeptide isosteres.
Kobayashi K; Oishi S; Hayashi R; Tomita K; Kubo T; Tanahara N; Ohno H; Yoshikawa Y; Furuya T; Hoshino M; Fujii N
J Med Chem; 2012 Mar; 55(6):2746-57. PubMed ID: 22352868
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective synthesis of [L-Arg-L/D-3-(2-naphthyl)alanine]-type (E)-alkene dipeptide isosteres and its application to the synthesis and biological evaluation of pseudopeptide analogues of the CXCR4 antagonist FC131.
Tamamura H; Hiramatsu K; Ueda S; Wang Z; Kusano S; Terakubo S; Trent JO; Peiper SC; Yamamoto N; Nakashima H; Otaka A; Fujii N
J Med Chem; 2005 Jan; 48(2):380-91. PubMed ID: 15658852
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of selective CXCR4 antagonists containing alkene dipeptide isosteres.
Narumi T; Hayashi R; Tomita K; Kobayashi K; Tanahara N; Ohno H; Naito T; Kodama E; Matsuoka M; Oishi S; Fujii N
Org Biomol Chem; 2010 Feb; 8(3):616-21. PubMed ID: 20090978
[TBL] [Abstract][Full Text] [Related]
6. Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesis.
Thiele S; Mungalpara J; Steen A; Rosenkilde MM; Våbenø J
Br J Pharmacol; 2014 Dec; 171(23):5313-29. PubMed ID: 25039237
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of cyclic peptide-based chemokine receptor CXCR4 antagonists: disclosing the importance of side-chain and backbone functionalities.
Ueda S; Oishi S; Wang ZX; Araki T; Tamamura H; Cluzeau J; Ohno H; Kusano S; Nakashima H; Trent JO; Peiper SC; Fujii N
J Med Chem; 2007 Jan; 50(2):192-8. PubMed ID: 17228861
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship study on artificial CXCR4 ligands possessing the cyclic pentapeptide scaffold: the exploration of amino acid residues of pentapeptides by substitutions of several aromatic amino acids.
Tanaka T; Nomura W; Narumi T; Esaka A; Oishi S; Ohashi N; Itotani K; Evans BJ; Wang ZX; Peiper SC; Fujii N; Tamamura H
Org Biomol Chem; 2009 Sep; 7(18):3805-9. PubMed ID: 19707686
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship study of CXCR4 antagonists bearing the cyclic pentapeptide scaffold: identification of the new pharmacophore.
Tanaka T; Tsutsumi H; Nomura W; Tanabe Y; Ohashi N; Esaka A; Ochiai C; Sato J; Itotani K; Murakami T; Ohba K; Yamamoto N; Fujii N; Tamamura H
Org Biomol Chem; 2008 Dec; 6(23):4374-7. PubMed ID: 19005596
[TBL] [Abstract][Full Text] [Related]
10. Rational design of conformationally constrained cyclopentapeptide antagonists for C-x-C chemokine receptor 4 (CXCR4).
Mungalpara J; Thiele S; Eriksen Ø; Eksteen J; Rosenkilde MM; Våbenø J
J Med Chem; 2012 Nov; 55(22):10287-91. PubMed ID: 23043442
[TBL] [Abstract][Full Text] [Related]
11. Development of novel CXC chemokine receptor 7 (CXCR7) ligands: selectivity switch from CXCR4 antagonists with a cyclic pentapeptide scaffold.
Oishi S; Kuroyanagi T; Kubo T; Montpas N; Yoshikawa Y; Misu R; Kobayashi Y; Ohno H; Heveker N; Furuya T; Fujii N
J Med Chem; 2015 Jul; 58(13):5218-25. PubMed ID: 26042340
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel low molecular weight CXCR4 antagonists by structural tuning of cyclic tetrapeptide scaffolds.
Tamamura H; Araki T; Ueda S; Wang Z; Oishi S; Esaka A; Trent JO; Nakashima H; Yamamoto N; Peiper SC; Otaka A; Fujii N
J Med Chem; 2005 May; 48(9):3280-9. PubMed ID: 15857134
[TBL] [Abstract][Full Text] [Related]
13. Conformational studies of stereoisomeric 14-membered cyclic enkephalin analogues containing 1-naphthylalanine at the fourth position: chirality effect of leucine at the fifth position on biological activity and receptor selectivity.
Yamazaki T; Said-Nejad OE; Schiller PW; Goodman M
Biopolymers; 1991 Jun; 31(7):877-98. PubMed ID: 1655089
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of gamma-MSH analogues at the human melanocortin MC3, MC4, and MC5 receptors. Discovery of highly selective hMC3R, hMC4R, and hMC5R analogues.
Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
J Med Chem; 2003 Nov; 46(23):4965-73. PubMed ID: 14584947
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship studies on CXCR4 antagonists having cyclic pentapeptide scaffolds.
Tamamura H; Esaka A; Ogawa T; Araki T; Ueda S; Wang Z; Trent JO; Tsutsumi H; Masuno H; Nakashima H; Yamamoto N; Peiper SC; Otaka A; Fujii N
Org Biomol Chem; 2005 Dec; 3(24):4392-4. PubMed ID: 16327900
[TBL] [Abstract][Full Text] [Related]
16. A minimalistic 3D pharmacophore model for cyclopentapeptide CXCR4 antagonists.
Våbenø J; Nikiforovich GV; Marshall GR
Biopolymers; 2006; 84(5):459-71. PubMed ID: 16552740
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of all diastereomers of cyclic pseudo-dipeptides as mimics of cyclic CXCR4 pentapeptide antagonists.
Cluzeau J; Oishi S; Ohno H; Wang Z; Evans B; Peiper SC; Fujii N
Org Biomol Chem; 2007 Jun; 5(12):1915-23. PubMed ID: 17551641
[TBL] [Abstract][Full Text] [Related]
18. Structure-function relationship studies of bovine parathyroid hormone [bPTH(1-34)] analogues containing alpha-amino-iso-butyric acid (Aib) residues.
Peggion E; Mammi S; Schievano E; Schiebler L; Corich M; Rosenblatt M; Chorev M
Biopolymers; 2003 Mar; 68(3):437-57. PubMed ID: 12601801
[TBL] [Abstract][Full Text] [Related]
19. Molecular modeling study of cyclic pentapeptide CXCR4 antagonists: new insight into CXCR4-FC131 interactions.
Yoshikawa Y; Kobayashi K; Oishi S; Fujii N; Furuya T
Bioorg Med Chem Lett; 2012 Mar; 22(6):2146-50. PubMed ID: 22365757
[TBL] [Abstract][Full Text] [Related]
20. Insight into the binding mode for cyclopentapeptide antagonists of the CXCR4 receptor.
Våbenø J; Nikiforovich GV; Marshall GR
Chem Biol Drug Des; 2006 May; 67(5):346-54. PubMed ID: 16784459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
